Introduction {#s1}
============

Osteoporosis is a common disease characterized by low bone mass, microarchitectural deterioration of bone tissue and enhanced bone fragility which leads to an increased incidence of fracture. It is now well established that genetic factors play a major role in regulating bone mineral density (BMD) \[[@B1]\]. Association studies have been used to identify genetic variants that are associated with BMD and fractures \[[@B2]--[@B6]\]. Recently, genome-wide association studies (GWAS) have been successful in further identifying several common variants that are significantly associated with BMD and with fracture risk \[[@B7]--[@B10]\].

The low-density lipoprotein receptor (LDLR)-related protein 5 (*LRP5*) gene is one of the candidate genes that have been implicated in BMD. As a member of the LDLR family, this gene contains 23 exons that span more than 100 kb and encodes a single-pass transmembrane protein of 1614 amino acids \[[@B11]\]. LRP5 cooperates with members of the frizzled family of seven-pass transmembrane receptors to bind Wnt proteins, and forms a functional ligand-receptor complex that activates the Wnt-β-catenin pathway \[[@B12]--[@B14]\]. This Wnt-β-catenin pathway is one of the key pathways to affect osteoblast development. It has been reported that loss-of-function mutations of the *LRP5* gene cause osteoporosis-pseudoglioma (OPPG), an autosomal recessive disease characterized by low bone mass and childhood fractures \[[@B15]\], whereas the *LRP5* G171V mutation is associated with autosomal dominant high bone mass (HBM) traits \[[@B16]--[@B18]\]. Transgenic and knock-out mouse models mimic the human phenotypes of high and low bone mass, respectively \[[@B19]\]. In addition to these mutations, a number of polymorphisms have been described in the *LRP5* gene. Among them, two coding polymorphisms A1330V (rs3736228) and V667M (rs4988321) were studied most, and were suggested to be associated with BMD \[[@B6],[@B20]--[@B24]\]. Another missense variant is Q89R (rs41494349) located in exon 2, which has been reported to be significantly associated with BMD among Asian population \[[@B25],[@B26]\].

Although many studies have investigated the relationship between these three *LRP5* polymorphisms and BMD, published results have been conflicting. This may be due to that individual studies based on restricted sample sizes lack sufficient statistical power to detect effects of interest. Therefore, we performed the present meta-analysis to clarify the association of the *LRP5* polymorphisms (A1330V, V667M and Q89R) with BMD.

Materials and Methods {#s2}
=====================

Literature search strategy {#s2.1}
--------------------------

The literature included in our analysis was selected from PubMed, EMBASE and ISI web of science using combinations of the following keywords: low-density lipoprotein receptor-related protein 5 gene (*LRP5*), polymorphism, A1330V (rs3736228), V667M (rs4988321), Q89R (rs41494349) and bone mineral density (BMD). Genetic association studies published before the end of March 1, 2013 on the association between BMD and polymorphisms in the *LRP5* gene were retrieved, and their references were checked to identify other relevant publications. The publication language was restricted to English.

Eligible studies and data extraction {#s2.2}
------------------------------------

Eligible studies had to meet all of the following criteria: (1) were published in peer-reviewed journals and were independent studies using original data; (2) investigated the effect of the *LRP5* polymorphisms on BMD; (3) provided sufficient data for calculation of weighted mean difference (WMD) with its 95 % confidence interval (CI) and *P* value; (4) described the genotyping method, equipment, and protocols used or provided reference to them. For each study, the following data were extracted independently by two authors: first author's surname, year of publication, age, gender, ethnicity, study site, genotyping method, total number of subjects, skeletal sites evaluated for BMD, and genotype and BMD data. The results were compared and disagreements were discussed and resolved with consensus. Studies with different gender, age and ethnic groups were considered as individual studies for our analyses.

Statistical analysis {#s2.3}
--------------------

We pooled eligible studies according to the site of BMD measurement and performed analyses at the lumbar spine (LS), total hip (HT), femoral neck (FN) and trochanter, respectively. The main analyses addressed differences in BMD between genotypes: AA versus AV/VV or AA versus VV for A1330V; VV versus VM/MM for Val667Met; QQ versus QR/RR for Q89R. We calculated the weighted mean difference (WMD) based on the actual BMD values reported in the included studies. Cochran's Chi square-based Q statistic test was performed to assess possible heterogeneity between the individual studies \[[@B27]\]. If heterogeneity existed (*P* \< 0.05) across studies, the random effects model was used \[[@B28]\]; otherwise, the fixed effect model was adopted \[[@B29]\]. We also performed subgroup analyses based on ethnicity (Caucasian and Asian) and gender (women and men).

Sensitivity analyses were performed to assess the stability of the results, namely, each study in the meta-analysis was deleted each time to reflect the influence of the individual dataset to the overall OR. Publication bias was assessed by Egger's test \[[@B30]\] and funnel-plot analysis. All *P* values are two-sided, and *P* \< 0.05 was considered statistically significant. All the statistical analyses were performed by Review Manager v.5.

Results {#s3}
=======

Characteristics of studies {#s3.1}
--------------------------

The literature search yielded 103 references. Study selection process is shown in [Figure 1](#pone-0085052-g001){ref-type="fig"} and [Table S1](#pone.0085052.s002){ref-type="supplementary-material"}. A total of 19 eligible studies \[[@B20]-[@B26],[@B31]-[@B42]\] were finally included with 25773 subjects (15871 women and 9902 men). For the A1330V polymorphism, 17 studies were available, including a total of 23837 subjects. For the V667M polymorphism, 8 studies involved a total of 14985 Caucasian subjects. For the Q89R polymorphism, 2 studies with a total of 1069 subjects were included, both of which were conducted in Asia. The detailed characteristics of all the studies and the main results in this meta-analysis are shown in [Tables 1](#pone-0085052-t001){ref-type="table"}, [2](#pone-0085052-t002){ref-type="table"}, [3](#pone-0085052-t003){ref-type="table"} and [4](#pone-0085052-t004){ref-type="table"}.

![Summary of search strategy and result.](pone.0085052.g001){#pone-0085052-g001}

10.1371/journal.pone.0085052.t001

###### Characteristics of individual studies included in the meta-analysis.

  Author                     Year   Gender          Country       Ethnicity   Age (mean ± SD)                                        Genotyping method                           Number   BMD                      SNP
  -------------------------- ------ --------------- ------------- ----------- ------------------------------------------------------ ------------------------------------------- -------- ------------------------ -----------------------
  Brixen\[[@B21]\]           2007   Men             Denmark       Caucasian   20-30                                                  TaqMan/Acyclo Prime-FP SNP Detection kits   783      LS, TH                   Ala1330Val
  Ezura\[[@B23]\]            2007   Women           Japan         Asian       64.6±10.8                                              Sd-PCR/Invader assay/TaqMan                 387      LS                       A1330V
  Giroux\[[@B24]\]           2007   Women           Canada        Caucasian   25-91                                                  Allele-specific PCR                         5144     LS, FN                   Val667Met, Ala1330Val
  Giroux\[[@B31]\]           2008   Women           Canada        Caucasian   18-58                                                  Allele-specific PCR                         1382     LS, FN                   Val667Met
  Grundberg \[[@B32]\]       2008   Men             Sweden        Caucasian   Sweden 74.4±3.2； Hong Kong 72.4±5.0；GOOD 18.9±0.56   TaqMan                                      6082     LS, FN                   Val667Met, Ala1330Val
  Jiang\[[@B33]\]            2010   Men and women   China         Asian       48.9±12.5                                              TaqMan                                      425      LS, TH                   A1330V
  Koh\[[@B25]\]              2004   Men             Korea         Asian       25.6±3.7                                               PCR-RFLP                                    219      LS, FN, trochanter       Q89R, A1330V
  Koller\[[@B34]\]           2005   Women           USA           Caucasian   33.3±7.0                                               Fluorescent allele-specific PCR/MALDI-TOF   1301     LS, FN                   A1330V
  Kruk\[[@B35]\]             2009   Men             UK            Caucasian   59.7±10.7                                              PCR-Sequencing                              249      LS, TH, FN, trochanter   Val667Met, Ala1330Val
  Markatseli \[[@B36]\]      2011   Women           Greece        Caucasian   56.8±4.9                                               TaqMan                                      221      LS                       Val667Met, Ala1330Val
  Massart\[[@B37]\]          2012   Women           Italy         Caucasian   20-50                                                  PCR-RFLP                                    570      LS, TH, FN               Val667Met, Ala1330Val
  Mencej- Bedrac\[[@B38]\]   2009   Men and women   Slovenia      Caucasian   62.3±9.5                                               PCR-RFLP                                    625      LS, FN                   A1330V
  Meurs\[[@B22]\]            2006   Men and women   Netherlands   Caucasian   \>50                                                   PCR-SBE                                     5373     LS, FN                   A1330V
  Mizuguchi \[[@B39]\]       2004   Women           Japan         Asian       54.2±12.4                                              PCR-Sequencing/TaqMan                       254      LS                       A1330V
  Riancho\[[@B42]\]          2011   Women           Spain         Caucasian   51-90                                                  Mass-array/ TaqMan                          873      FN                       A1330V
  Saarinen\[[@B20]\]         2007   Men             Finland       Caucasian   18-21                                                  PCR-Sequencing                              235      LS, TH, FN, trochanter   A1330V
  Stathopoulou\[[@B40]\]     2010   Women           Greece        Caucasian   \>50                                                   iPLEX Gold assay                            554      LS, TH, FN, trochanter   Val667Met
  Yu\[[@B41]\]               2010   Men             China         Asian       30.6±6.3                                               PCR-RFLP                                    422      LS, TH, FN, trochanter   A1330V
  Zhang\[[@B26]\]            2005   Women           China         Asian       60.1±6.3                                               PCR-RFLP                                    647      LS, FN, trochanter       Q89R, A1330V

BMD: bone mineral density; TH: total hip;LS: lumbar spine; FN: femur neck.

10.1371/journal.pone.0085052.t002

###### Meta-analysis of the A1330V polymorphism and BMD association.

  Site of BMD   LS                 TH                                                                                                        
  ------------- ------------------ --------------------- -------------- -------------- ------------------ ---------------------- ----------- --------------
  Overall                                                                                                                                    
  AA vs AV/VV   11                 0.02 \[0.01,0.03\]    **\<10^-4^**   51% (0.02)     2                  0.03 \[-0.07,0.14\]    0.53        91% (0.001)
  AA vs VV      11                 0.02 \[0.01,0.04\]    **0.01**       6% (0.39)      7                  0.00 \[-0.05,0.05\]    1.00        67% (0.006)
  Ethnicity                                                                                                                                  
  Caucasian     7                  0.02 \[0.01,0.03\]    **0.001**      67% (0.005)    5                  -0.04 \[-0.08,0.00\]   0.05        0% (0.42)
  Asian         4                  0.01 \[0.00,0.02\]    **0.04**       0% (0.68)      2                  0.07 \[-0.01,0.15\]    0.07        64% (0.09)
  Gender                                                                                                                                     
  Women         5                  0.03 \[0.01,0.04\]    **0.0003**     65% (0.02)     3                  -0.06 \[-0.13,0.01\]   0.11        0% (0.65)
  Men           6                  0.01 \[0.00,0.02\]    **0.04**       0% (0.47)      3                  0.00 \[-0.07,0.06\]    0.89        69% (0.04)
  Site of BMD   FN                 Trochanter                                                                                                
  Subgroup      No. of data sets   WMD \[95% CI\]        *P* value      *I* ^2^(*P*)   No. of data sets   WMD \[95% CI\]         *P* value   *I* ^2^(*P*)
  Overall                                                                                                                                    
  AA vs AV/VV   8                  0.01 \[0.00,0.02\]    **0.01**       52% (0.04)     3                  -0.00 \[-0.01,0.02\]   0.59        83% (0.003)
  AA vs VV      9                  0.00 \[-0.01,0.02\]   0.67           24% (0.23)     2                  -0.03 \[-0.13,0.09\]   0.76        85% (0.009)
  Ethnicity                                                                                                                                  
  Caucasian     6                  0.01 \[0.01,0.02\]    **0.01**       56% (0.04)     2                  -0.01 \[-0.03,0.01\]   0.47        90% (0.001)
  Asian         2                  0.00 \[-0.01,0.01\]   0.60           0% (0.36)      1                  0.01 \[-0.01,0.03\]    0.22        NA
  Gender                                                                                                                                     
  Women         3                  0.01 \[0.01,0.02\]    **\<10^-4^**   0% (0.39)      1                  0.01 \[-0.01,0.03\]    0.22        NA
  Men           5                  0.01 \[-0.00,0.01\]   0.14           62% (0.03)     2                  -0.01 \[-0.03,0.01\]   0.47        90% (0.001)

10.1371/journal.pone.0085052.t003

###### Meta-analysis of the V667M polymorphism and BMD association.

  Site of BMD   LS                 TH                                                                                                        
  ------------- ------------------ --------------------- -------------- -------------- ------------------ ---------------------- ----------- --------------
  Overall                                                                                                                                    
  VV vs VM/MM   10                 0.02 \[0.02,0.03\]    **\<10^-5^**   19% (0.27)     5                  0.01 \[-0.01,0.02\]    0.43        23% (0.27)
  Ethnicity                                                                                                                                  
  Caucasian     10                 0.02 \[0.02,0.03\]    **\<10^-5^**   19% (0.27)     5                  0.01 \[-0.01,0.02\]    0.43        23% (0.27)
  Gender                                                                                                                                     
  Women         7                  0.03 \[0.02,0.03\]    **\<10^-5^**   39% (0.13)     4                  0.01 \[-0.01,0.03\]    0.32        37% (0.19)
  Men           3                  0.02 \[0.00,0.04\]    **0.01**       0% (0.61)      1                  0.00 \[-0.04,0.3\]     0.87        NA
  Site of BMD   FN                 Trochanter                                                                                                
  Subgroup      No. of data sets   WMD \[95% CI\]        *P* value      *I* ^2^(*P*)   No. of data sets   WMD \[95% CI\]         *P* value   *I* ^2^(*P*)
  Overall                                                                                                                                    
  VV vs VM/MM   9                  0.01 \[0.01,0.02\]    **0.0002**     42% (0.09)     2                  0.01 \[-0.01,0.03\]    0.31        0% (0.34)
  Ethnicity                                                                                                                                  
  Caucasian     9                  0.01 \[0.01,0.02\]    **0.0002**     42% (0.09)     2                  0.01 \[-0.01,0.03\]    0.31        0% (0.34)
  Gender                                                                                                                                     
  Women         6                  0.02 \[0.01,0.02\]    **\<10^-4^**   52% (0.06)     1                  0.02 \[-0.01,0.05\]    0.16        NA
  Men           3                  0.00 \[-0.01,0.02\]   0.58           0% (0.51)      1                  -0.00 \[-0.04,0.03\]   0.91        NA

10.1371/journal.pone.0085052.t004

###### Meta-analysis of the Q89R polymorphism and BMD association.

  Site of BMD     LS                 FN                                                                                                    
  --------------- ------------------ --------------------- ----------- -------------- ------------------ --------------------- ----------- --------------
  Subgroup        No. of data sets   WMD \[95% CI\]        *P* value   *I* ^2^(*P*)   No. of data sets   WMD \[95% CI\]        *P* value   *I* ^2^(*P*)
  Overall                                                                                                                                  
  QQ vs QR/RR     2                  0.00 \[-0.02,0.03\]   0.89        0% (0.86)      2                  0.03 \[0.01,0.05\]    **0.005**   72% (0.06)
  Ethnicity                                                                                                                                
  Asian           2                  0.00 \[-0.02,0.03\]   0.89        0% (0.86)      2                  0.03 \[0.01,0.05\]    **0.005**   72% (0.06)
  Gender                                                                                                                                   
  Women           1                  0.00 \[-0.03,0.03\]   0.83        NA             1                  0.02 \[-0.00,0.04\]   0.1         NA
  Men             1                  0.00 \[-0.05,0.04\]   0.93        NA             1                  0.06 \[0.02,0.10\]    **0.003**   NA
  Site of BMD     Trochanter                                                                                                               
  Subgroup        No. of data sets   WMD \[95% CI\]        *P* value   *I* ^2^(*P*)                                                        
  Overall                                                                                                                                  
  QQ vs QR/RR     2                  0.02 \[-0.00,0.03\]   0.10        23% (0.25)                                                          
  Ethnicity                                                                                                                                
  Caucasian       2                  0.02 \[-0.00,0.03\]   0.10        23% (0.25)                                                          
  Gender                                                                                                                                   
  Women           1                  0.01 \[-0.01,0.03\]   0.26        NA                                                                  
  Men             1                  0.04 \[-0.01,0.09\]   0.10        NA                                                                  

Association of the LRP5 A1330V polymorphism with BMD {#s3.2}
----------------------------------------------------

There were 17 studies analyzing LS BMD, 6 analyzing TH BMD, 12 analyzing FN BMD and 5 focused on trochanter BMD. In the pooled analyses, individuals with the AA genotype were found to have a statistically significant association with BMD compared to subjects with the AV/VV (at LS: WMD = 0.02 g/cm^2^, 95% CI = 0.01-0.03, *P* \< 10^-4^; at FN: WMD = 0.01 g/cm^2^, 95% CI = 0.00-0.02, *P* = 0.01) ([Figure 2 and Figure 3](#pone-0085052-g002){ref-type="fig"}) or VV genotype (at LS: WMD = 0.02 g/cm^2^, 95% CI = 0.01-0.04, *P* = 0.01). Similar results were obtained when stratified by gender and ethnicity for AA versus AV/VV ([Table 2](#pone-0085052-t002){ref-type="table"}). Interestingly, the association was not found in men \[WMD = 0.01 g/cm^2^, 95% CI = (-0.00)-0.01, *P* = 0.14\] or Asians \[WMD = 0.00 g/cm^2^, 95% CI = (-0.01)-0.01, *P* = 0.60\] in the analysis of FN BMD. We did not observe any significant association for BMD of TH and trochanter ([Table 2](#pone-0085052-t002){ref-type="table"}).

![WMD and 95% CI in LS BMD between A1330V AA and AV/VV genotypes.](pone.0085052.g002){#pone-0085052-g002}

![WMD and 95% CI in FN BMD between A1330V AA and AV/VV genotypes.](pone.0085052.g003){#pone-0085052-g003}

Association of the LRP5 V667M polymorphism with BMD {#s3.3}
---------------------------------------------------

For BMD of LS, 7 studies with 8242 women and 4323 men were identified for the data analysis. Individuals with the VV genotype showed a significantly greater BMD than those with the VM/MM genotype (WMD = 0.02 g/cm^2^, 95% CI = 0.02--0.03, *P* \< 10^-5^) without between-study heterogeneity (*P* = 0.27) ([Figure 4](#pone-0085052-g004){ref-type="fig"}). Similar significant associations were observed when women and men genotypes were analyzed separately ([Table 3](#pone-0085052-t003){ref-type="table"}). For BMD of FN, a total of 10973 subjects based on 6 studies were identified for the data analysis. There was a significant association detected between the polymorphism and BMD (VV vs. VM/MM: WMD = 0.01 g/cm^2^, 95% CI = 0.01--0.02, *P* = 0.0002) ([Figure 5](#pone-0085052-g005){ref-type="fig"}). However, no association was found for men in the subgroup analysis stratified by gender \[VV vs. VM/MM: WMD = 0.00 g/cm^2^, 95% CI = (-0.01)-0.02, *P* = 0.58\]. Furthermore, our data showed no statistical evidence of significant association between this SNP and BMD of TH and trochanter ([Table 3](#pone-0085052-t003){ref-type="table"}).

![WMD and 95% CI in LS BMD between V667M VV and VM/MM genotypes.](pone.0085052.g004){#pone-0085052-g004}

![WMD and 95% CI in FN BMD between V667M VV and VM/MM genotypes.](pone.0085052.g005){#pone-0085052-g005}

Association of the LRP5 Q89R polymorphism with BMD {#s3.4}
--------------------------------------------------

Two studies analyzed the relationship between Q89R and the BMD of LS, FN and trochanter among a total of 1069 Asian subjects. There was a significant association between the *LRP5* Q89R polymorphism and FN BMD (QQ vs. QR/RR: WMD = 0.03 g/cm^2^, 95% CI = 0.01--0.05, *P* = 0.005) without between-study heterogeneity (*P* = 0.06) ([Figure 6](#pone-0085052-g006){ref-type="fig"}). When stratified by gender, significant association was found only in men (QQ vs. QR/RR: WMD = 0.06 g/cm^2^, 95% CI = 0.02--0.10, *P* = 0.003), but not in women ([Table 4](#pone-0085052-t004){ref-type="table"}). The results of our meta-analyses for LS and trochanter BMD indicated no significant associations \[LS: WMD = 0.00 g/cm^2^, 95% CI = (-0.02)-0.03, *P* = 0.89; trochanter: WMD = 0.02 g/cm^2^, 95% CI = (-0.00)-0.03, *P* = 0.10\].

![WMD and 95% CI in FN BMD between Q89R QQ and QR/RR genotypes.](pone.0085052.g006){#pone-0085052-g006}

Sensitivity analysis and potential publication bias {#s3.5}
---------------------------------------------------

Sensitivity analysis was conducted by deleting each study at a time to reflect the influence of the individual dataset to the pooled WMDs, and the corresponding results were not qualitatively altered. The inverted funnel plots were symmetrical as shown in [Figures S1-S5](#pone.0085052.s003){ref-type="supplementary-material"}. Egger's test was also performed to access the publication bias of the literatures, and no publication bias was detected for the associations of the *LRP5* polymorphisms with BMD phenotypes (all *P* \> 0.05).

Discussion {#s4}
==========

In this meta-analysis, we investigated the association of the *LRP5* A1330V, V667M and Q89R polymorphisms with BMD. The *LRP5* gene is a known locus associated with BMD in several genome-wide association studies (GWASs). Although early studies were carried out in Caucasians \[[@B6]-[@B8]\], the 11q13 locus (*LRP5*) was also reported to be associated with BMD in replication study in the East-Asians \[[@B43]\]. There were meta-analyses on the association between the *LRP5* gene and BMD \[[@B44],[@B45]\], however, both studies only examined the influence of the A1330V polymorphism on BMD. Moreover, limited studies were included in both meta-analyses. In the present study, more unbiased new articles with a larger sample size could provide new insight into the underlying relationship between the *LRP5* gene and BMD. This is the most comprehensive meta-analysis focused on the associations of the A1330V, Val667Met and Q89R polymorphisms with BMD, which involved 19 studies with 25773 subjects in total. Our results suggested that the A1330V and Val667Met polymorphisms were related to LS and FN BMDs, and that the Q89R polymorphism was associated with FN BMD.

There have been several studies reported that the A1330V polymorphism is associated with BMD, and that individuals with the AV/VV or VV genotype have lower BMD than those with the AA genotype. Our data also supported a significant association between this SNP and BMD at LS and FN among Caucasian populations, which is consistent with previous GWAS studies \[[@B7]\]. However, we did not detect any association of this polymorphism with FN BMD among men or Asians. It has been observed that the relative distribution of the A1330V genotypes varied remarkably between genders as well as among different populations. For example, the AA genotype was 46%-73.5% in Asian women \[[@B23],[@B25]\], however, much higher (73%) in Dutch women \[[@B22]\]. Among Caucasian populations, the AA genotype was detected in 56% of Dutch men \[[@B22]\], 91% of Finnish men \[20\], and 76% of Danish men \[[@B21]\]. In addition, there were statistically significant differences in A1330-allele frequencies with regard to gender in our study (*P* \< 0.05). Possible explanation for the gender-related differences might be that sex-specific hormones (such as androgens and estrogens) were involved in the regulation of *LRP5*. LRP5, with its close homolog LRP6, functions as a cell membrane co-receptor for Wnt proteins in the canonical Wnt signaling pathway. Interestingly, a previous study reported the direct evidence of cross-talk between Wnt and estrogen signaling pathways via functional interaction between β-catenin and estrogen receptor (ER)-α*in vivo* \[[@B46]\]. The results from another more recent article also suggested the osteoporotic phenotype of ER knock-in (ERα^−/NERKI^) mice may involve the suppression of lymphoid enhancer factor-1 (Lef1)-mediated Wnt signaling \[[@B47]\]. Moreover, the study by Noh et al. \[[@B48]\] showed the *Lef1* haploinsufficient (*Lef1* ^*+/-*^) mice display low bone mass phenotype in a gender- and age- specific manner. The findings of these functional studies, combined with our results, indicated that the effect of the *LRP5* gene on BMD might be affected by gender.

For the analysis of V667M, our study consisted of 7 articles which were all using Caucasian subjects, while the analysis for the Q89R polymorphism included two studies both performed in Asian population. Significant association was observed between the V667M polymorphism and BMDs at LS and FN, which agreed with previous studies \[[@B21],[@B24],[@B31],[@B32],[@B36],[@B40]\]. We also found that subjects with the Q89R QQ genotype tended to have high BMD than those with QR/RR genotypes. Our results appeared to be further supported by the positions at which these polymorphisms were situated in the *LRP5* gene. LRP5 is a single pass membrane receptor whose extracellular protein contains four domains resembling a propeller with six blades containing YWTD spacer repeats followed by an epidermal growth factor (EGF)-like module, and an LDL receptor-like ligand-binding domain \[[@B49],[@B50]\]. The Q89R polymorphism is located in exon 2, which encodes the first of four propellers, while V667M is localized at the top of the third propeller module. Although the precise function of each region is uncertain, the four propellers are of structural importance. It has been suggested that mutation in the first propeller region can alter the local hydrophobic environment, thus possibly affecting the interaction of LRP5 with other proteins \[[@B18]\]. In addition, the A1330V polymorphism is in exon 18 encoding the LDL receptor-like domain. It has been reported that a number of mutations in the LDL receptor propeller module can cause familial hypercholesterolemia \[[@B49]\], confirming that this domain is important for protein function. These findings provide evidence that all these polymorphisms might have the ability to alter the LRP5 activity, which in turn had an impact on BMD. But the question that arises is to what extent each SNP would exert influence on BMD.

The Q89R and A1330V polymorphisms were in linkage disequilibrium in Korean and Chinese populations \[[@B25],[@B26]\], but not among a European population \[[@B51]\]. Strong linkage disequilibrium was also observed between the SNPs V667M and A1330V \[[@B22],[@B34],[@B52]\]. In the study by van Meurs et al. \[[@B22]\], the haplotype analysis indicated that the A1330V polymorphism was probably driving the association with BMD, because two haplotypes containing the 1330V variant showed an association with low BMD and other bone-related endpoints, whereas the other haplotypes did not. It has been found that another SNP at the intron 17 (IVS17-1677C\>A) in the *LRP5* gene was related to total body BMD in Japanese subjects \[[@B53]\]. Further study by the same team showed that the IVS17-1677C\>A SNP and A1330V were in strong linkage disequilibrium \[[@B23]\]. These data suggested a possibility that the A1330V polymorphism or other polymorphisms in linkage disequilibrium with it, which have not been identified yet, might be the main driving force behind the association with BMD. However, replications of this association in different ethnic populations as well as *in vitro* functional studies are warrant to validate the hypothesis.

In interpreting the results, some limitations of this meta-analysis should be addressed. First, our results were based on unadjusted estimates, while a more precise analysis should be conducted if all individual raw data were available, which would allow for the adjustment by other covariates including age, body height, body weight, and exercises habits. Second, the analysis for V667M was totally based on data of Caucasian subjects, while the analysis for Q89R was based on two studies performed in Asians. Notably, the V667M SNP was not polymorphic in the Hong Kong population \[[@B32]\], and the Q89R polymorphism was very rare in Caucasians \[[@B51],[@B54]\]. Therefore, additional studies in different populations focused on other loci which are in LD with these variations are needed to further validate ethnic difference in their effects on BMD. Third, the effects of gene-gene or gene-environment interactions were not addressed in this meta-analysis. However, most studies did not provide the detailed information, which impeded us for further analysis.

In conclusion, the present study is the most comprehensive meta-analysis investigating the associations of the *LRP5* polymorphisms with BMD. And our data demonstrated that the A1330V and V667M polymorphisms were significantly associated with BMDs at LS and FN, while the Q89R polymorphism was significantly associated with FN BMD. For future association studies, more accurate phenotype and genotype data, detailed individual information, larger sample size of different ethnic populations and standard statistical methods will be needed. Moreover, the interactions between gene-gene and gene-environment should also be evaluated.
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**Funnel plot for FN BMD between Q89R QQ and QR/RR genotypes.**
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